Fenbendazole (FZ) is a broad-spectrum benzimidazole anthelminthic that is used to treat parasites and worms in a variety of animal species. It is readily available at pet stores without prescription.

In addition to its antihelminthic properties, fenbendazole has also been shown to depolymerize microtubules and induce cancer cell death in vitro. Its antitumor activity is attributed to disruption of MT dynamics, p53 activation and the modulation of genes involved in multiple pathways. It also reduces glucose uptake in cancer cells by downregulation of key glycolytic enzymes and GLUT transporters.

There is a growing body of scientific research suggesting that several benzimidazole medications – including albendazole, mebendazole and fenbendazole – may have anticancer properties. Unfortunately, these drugs do not have the benefit of a proven clinical trial track record in humans, so they cannot be easily repurposed as potential human cancer treatments.

Recently, an anecdotal story has emerged about a man named Joe Tippens who was diagnosed with Stage 4 pancreatic cancer and given three months to live by his doctors. He decided to try a protocol that involved taking fenbendazole along with curcumin and CBD. The result was that he completely reversed his cancer. This story has been spreading like wildfire on social media and is gaining the attention of scientists and physicians. fenben for humans